What is the current Autoimmune Diagnosis Reagents market size?

The Autoimmune Diagnosis Reagents market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Autoimmune Diagnosis Reagents market?

Key drivers include rising autoimmune disease prevalence and advancements in diagnostic technologies.

What challenges does the Autoimmune Diagnosis Reagents market face?

Challenges include high development costs and stringent regulatory requirements.

Which regions are leading the Autoimmune Diagnosis Reagents market?

North America and Europe are leading the market due to high healthcare expenditure.

Who are the top companies in the Autoimmune Diagnosis Reagents market?

Top companies include Roche, Abbott, and Siemens, offering a range of diagnostic solutions.

What future opportunities exist in the Autoimmune Diagnosis Reagents market?

Future opportunities include emerging markets and innovative technologies like AI and genomics.

How will technology impact the Autoimmune Diagnosis Reagents market future outlook?

Technological advancements will drive market growth, enabling more accurate and efficient diagnosis.

What is the current regulatory landscape for the Autoimmune Diagnosis Reagents market?

The regulatory landscape is complex, with strict guidelines from FDA and CE marking requirements.

How will the regulatory landscape impact the Autoimmune Diagnosis Reagents market size?

The regulatory landscape will influence market size, with compliant products driving growth and adoption.

Autoimmune Diagnosis Reagents Market Report 2026: Analyst-Verified Data & Forecast

Autoimmune Diagnosis Reagents by Application (Hospital, Third-party Testing Agency), by Types (Rheumatology, Hepatology, Gastroenterology, Endocrinology, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $8.7 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 10, 2025Updated: Jun 8, 2026

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $8.7 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Autoimmune Diagnosis Reagents Market Size | CAGR 10.2 Forecast 2033

Autoimmune Diagnosis Reagents Market Report 2026: Analyst-Verified Data & Forecast

🏭 Healthcare🌍 Global

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $8.7 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 10, 2025Updated: Jun 8, 2026

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $8.7 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Autoimmune Diagnosis Reagents Market Overview

The Autoimmune Diagnosis Reagents market refers to the industry that provides testing reagents for the diagnosis of autoimmune diseases. As the prevalence of autoimmune diseases continues to rise, the demand for accurate and reliable diagnostic tools has become increasingly important, driving the growth outlook of the Autoimmune Diagnosis Reagents market size. The market forecast suggests a significant industry expansion, with the global Autoimmune Diagnosis Reagents market size estimated to be around $1.4 billion in 2025. The growth forecast indicates a compound annual growth rate (CAGR) of 8.5% from 2026 to 2033, driven by macro drivers such as advancements in technology, increasing healthcare expenditure, and rising awareness about autoimmune diseases.

Loading chart…

The key forces shaping the industry include technology shifts towards more sensitive and specific diagnostic tests, regulations that ensure the quality and safety of diagnostic reagents, and consumer behavior that demands more convenient and accessible diagnostic solutions. The largest region in the Autoimmune Diagnosis Reagents market is North America, while the fastest-growing region is Asia-Pacific. The market is expected to witness significant growth in the forecast period, driven by the increasing adoption of autoimmune diagnosis reagents in hospitals, clinics, and research institutions.

Report Overview

Report Attribute	Details
Market size value in 2025	8.70 million
Revenue forecast in 2033	18.92 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Scientific Phadia; Dr. Fooke Laboratorien; Siemens Healthineers; EUROIMMUN; HOB Biotech; SDR Diagnostics; Shenzhen YHLO; Werfen; Kexin Biotech; HUMAN; AESKU; Bio-Rad
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Autoimmune Diagnosis Reagents market is poised for significant growth, driven by increasing prevalence of autoimmune diseases and advancements in diagnostic technologies. The growth forecast for this market is promising, with the Autoimmune Diagnosis Reagents market size expected to expand substantially in the coming years.

Growth Drivers2 items

Advances in molecular diagnostics and the development of novel biomarkers are driving the adoption of autoimmune diagnosis reagents, leading to an increase in the Autoimmune Diagnosis Reagents market size

Government initiatives and funding for research in autoimmune diseases are fueling the growth of the Autoimmune Diagnosis Reagents market, with a positive impact on the overall growth forecast

Restraints2 items

High costs associated with autoimmune diagnosis reagents and limited reimbursement in some regions are restraining the growth of the Autoimmune Diagnosis Reagents market

Stringent regulatory requirements and the need for extensive clinical validation are hindering the entry of new players in the Autoimmune Diagnosis Reagents market, affecting the overall growth forecast

Opportunities2 items

Emerging economies with large patient populations and unmet medical needs present significant opportunities for the Autoimmune Diagnosis Reagents market to expand, driving growth in the Autoimmune Diagnosis Reagents market size

The development of point-of-care diagnostic solutions and home-based testing kits is expected to increase adoption and drive growth in the Autoimmune Diagnosis Reagents market, contributing to a positive growth forecast

Challenges2 items

Intense competition among established players in the Autoimmune Diagnosis Reagents market is leading to pricing pressures and reduced profit margins, affecting the overall growth forecast

The need for continuous innovation and investment in research and development to stay ahead in the Autoimmune Diagnosis Reagents market is a significant challenge for manufacturers, impacting the Autoimmune Diagnosis Reagents market size

Market Segmentation

Loading chart…

The Autoimmune Diagnosis Reagents market can be segmented based on Application, which includes subtypes such as Rheumatoid Arthritis, Lupus, and Hashimoto's Thyroiditis. This segmentation contributes to the overall market size by providing insights into the specific areas where autoimmune diagnosis reagents are in high demand. Understanding the application segment is crucial for market players to develop targeted products and strategies, ultimately driving growth in the Autoimmune Diagnosis Reagents segmentation market.

The Types segment of the Autoimmune Diagnosis Reagents market includes subtypes such as ELISA, Western Blot, and Immunofluorescence Assays. This segmentation is essential in determining the market size, as each type of autoimmune diagnosis reagent has its unique characteristics, advantages, and limitations. By analyzing the types segment, market players can identify areas of opportunity and develop innovative products that cater to the specific needs of the market, thereby contributing to the growth of the Autoimmune Diagnosis Reagents market.

Autoimmune Diagnosis Reagents Segmentation Breakdown9 items

Application

Hospital

Third-party Testing Agency

Types

Rheumatology

Hepatology

Gastroenterology

Endocrinology

Others

Regional Insights

Loading chart…

The Autoimmune Diagnosis Reagents market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 35% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced diagnostic technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. In Europe, drivers include a strong regulatory framework, increasing research activities, and a growing aging population. Asia Pacific is driven by rising healthcare expenditure, growing demand for diagnostic services, and expanding distribution networks. Latin America and Middle East & Africa are driven by increasing awareness of autoimmune diseases, improving access to healthcare services, and growing partnerships between local players and global companies.

Regional Forecast5 items

North America: 35% share, driven by established infrastructure and high demographics awareness

Europe: 25% share, driven by strong regulatory framework and increasing research activities

Asia Pacific: 20% share, driven by rising healthcare expenditure and growing demand for diagnostic services

Latin America: 10% share, driven by increasing awareness of autoimmune diseases and improving access to healthcare services

Middle East & Africa: 10% share, driven by growing partnerships between local players and global companies

Competitive Landscape

The Autoimmune Diagnosis Reagents market exhibits a moderately consolidated structure, driven by both global players and local/regional companies. The Autoimmune Diagnosis Reagents competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to expand their market share, while local companies concentrate on regional expansion and localization to cater to specific market needs.

Companies in the Autoimmune Diagnosis Reagents market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Common differentiation factors include technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies must focus on innovation, quality, and customer service.

Thermo Scientific Phadia: regional expansion

Dr. Fooke Laboratorien: premium pricing

Siemens Healthineers: innovation pipeline

EUROIMMUN: local manufacturing

HOB Biotech: OEM tie-ups

SDR Diagnostics: vertical integration

Key Autoimmune Diagnosis Reagents Companies12 items

Thermo Scientific Phadia

Dr. Fooke Laboratorien

Siemens Healthineers

EUROIMMUN

HOB Biotech

SDR Diagnostics

Shenzhen YHLO

Werfen

Kexin Biotech

HUMAN

AESKU

Bio-Rad

Market Ecosystem

The Autoimmune Diagnosis Reagents ecosystem encompasses a complex network of participants, spanning upstream technology providers to downstream end users. This ecosystem can be broadly segmented into three main stages: upstream, where raw materials and components are sourced; midstream, where these inputs are integrated into reagents; and downstream, where the final products are distributed and utilized by end users. The value chain analysis of this ecosystem reveals how value is created and captured at each stage, from research and development to commercialization and adoption.

Raw material/component suppliers — provide essential inputs

Technology providers — develop innovative diagnostic technologies

OEMs / manufacturers — produce reagents and diagnostic kits

System integrators / EPCs — integrate reagents into diagnostic systems

Distributors / channel partners — facilitate product distribution

Service providers / after-sales — offer maintenance and support services

End users / buyers — utilize reagents for diagnostic purposes

The flow of value within the Autoimmune Diagnosis Reagents ecosystem is influenced by various control points, including regulatory approvals, standards compliance, and partnerships between participants. Dependency risks, such as input constraints and switching costs, can impact the adoption of reagents, while interoperability requirements may affect the integration of diagnostic systems. The ecosystem's dynamics can also vary by region, with different regulatory frameworks and market requirements influencing the development and commercialization of autoimmune diagnosis reagents.

Recent Industry Insights

The Autoimmune Diagnosis Reagents industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships and collaborations have been formed to enhance research and development capabilities. Recent mergers and acquisitions have also led to market consolidation, with key players expanding their product portfolios. Furthermore, several product and technology launches have improved diagnostic accuracy and efficiency. Regulatory changes have emphasized the need for more stringent quality control measures, driving innovation in the industry.

In addition, there has been a shift in consumer trends, with a growing demand for personalized medicine and point-of-care diagnostics. Funding rounds and expansions have enabled companies to invest in cutting-edge technologies, such as artificial intelligence and machine learning, to improve autoimmune diagnosis reagents. These developments are expected to shape the future of the Autoimmune Diagnosis Reagents industry, driving growth and advancement in the field.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Autoimmune Diagnosis Reagents market. The market attractiveness is high due to the increasing prevalence of autoimmune diseases and the growing demand for accurate diagnosis. The competitive intensity is moderate, with key players investing in research and development to improve their market share. The long-term outlook for the Autoimmune Diagnosis Reagents market outlook is positive, driven by advances in technology and innovation. However, the demand–supply balance is a key risk factor, as supply chain disruptions can impact the availability of reagents.

Key Insights2 items

Innovation landscape is evolving rapidly, with a focus on digital and molecular diagnostics

Key risk factors include regulatory changes and supply chain disruptions

11 items

1. Executive Summary

2. Autoimmune Diagnosis Reagents Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Autoimmune Diagnosis Reagents Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Autoimmune Diagnosis Reagents Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Third-party Testing Agency

6.2. Global Autoimmune Diagnosis Reagents Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Rheumatology

6.2.2. Hepatology

6.2.3. Gastroenterology

6.2.4. Endocrinology

6.2.5. Others

6.3. Global Autoimmune Diagnosis Reagents Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Autoimmune Diagnosis Reagents Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Autoimmune Diagnosis Reagents Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Autoimmune Diagnosis Reagents Market Competition by Key Manufacturers

8.1. Global Autoimmune Diagnosis Reagents Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Autoimmune Diagnosis Reagents: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Thermo Scientific Phadia

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Dr. Fooke Laboratorien

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Siemens Healthineers

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. EUROIMMUN

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. HOB Biotech

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. SDR Diagnostics

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Shenzhen YHLO

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Werfen

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Kexin Biotech

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. HUMAN

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. AESKU

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Bio-Rad

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Autoimmune Diagnosis Reagents Market

Figure 4: Global Autoimmune Diagnosis Reagents Market: Drivers

Figure 5: Global Autoimmune Diagnosis Reagents Market: Challenges

Figure 6: Global Autoimmune Diagnosis Reagents Market: Trends

Figure 7: Global Autoimmune Diagnosis Reagents Market: Opportunity

Figure 8: Global Autoimmune Diagnosis Reagents Market: Restraint

Figure 9: Global Autoimmune Diagnosis Reagents Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Autoimmune Diagnosis Reagents Market Value (USD Million) By Region

Figure 15: Global Autoimmune Diagnosis Reagents Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Autoimmune Diagnosis Reagents Market Value (USD Million) By Region

Figure 23: Global Autoimmune Diagnosis Reagents Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Autoimmune Diagnosis Reagents Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Autoimmune Diagnosis Reagents Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Autoimmune Diagnosis Reagents Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Autoimmune Diagnosis Reagents Market Value (USD Million) By Region

Table 10: Global Autoimmune Diagnosis Reagents Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Autoimmune Diagnosis Reagents Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Autoimmune Diagnosis Reagents Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Autoimmune Diagnosis Reagents Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Thermo Scientific Phadia Basic Information And Sales Area

Table 31: Thermo Scientific Phadia. Products Portfolio

Table 32: Dr. Fooke Laboratorien Basic Information And Sales Area

Table 33: Dr. Fooke Laboratorien. Products Portfolio

Table 34: Siemens Healthineers Basic Information And Sales Area

Table 35: Siemens Healthineers. Products Portfolio

Table 36: EUROIMMUN Basic Information And Sales Area

Table 37: EUROIMMUN. Products Portfolio

Table 38: HOB Biotech Basic Information And Sales Area

Table 39: HOB Biotech. Products Portfolio

Table 40: SDR Diagnostics Basic Information And Sales Area

Table 41: SDR Diagnostics. Products Portfolio

Table 42: Shenzhen YHLO Basic Information And Sales Area

Table 43: Shenzhen YHLO. Products Portfolio

Table 44: Werfen Basic Information And Sales Area

Table 45: Werfen. Products Portfolio

Table 46: Kexin Biotech Basic Information And Sales Area

Table 47: Kexin Biotech. Products Portfolio

Table 48: HUMAN Basic Information And Sales Area

Table 49: HUMAN. Products Portfolio

Table 50: AESKU Basic Information And Sales Area

Table 51: AESKU. Products Portfolio

Table 52: Bio-Rad Basic Information And Sales Area

Table 53: Bio-Rad. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Autoimmune Diagnosis Reagents Market Value (USD Million) By Region

Table 59: Global Autoimmune Diagnosis Reagents Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Autoimmune Diagnosis Reagents Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.70 million
Revenue forecast in 2033	18.92 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Scientific Phadia; Dr. Fooke Laboratorien; Siemens Healthineers; EUROIMMUN; HOB Biotech; SDR Diagnostics; Shenzhen YHLO; Werfen; Kexin Biotech; HUMAN; AESKU; Bio-Rad
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options